{"name":"OnCusp Therapeutics, Inc.","slug":"oncusp-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"OnCusp Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer. The company's lead candidate, CUSP06, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQelVMOWlTSGc2b2l3NG1TaTl3bUx1Y25nRmdtSU1td1N0cV9tUVJIS3N1ejRTX2ctVTROSmFGMERXdnZid1lEUUtWeHhZVkhpbzl1WEJlbVAtNzV2MS0zc2ZTQTBnY1hTc1laRkJpbkhSRTgtckhldUxIUXRPOHMyTkJEelNuNFhaUGNUSmRpOEFXbkQ0TlE?oc=5","date":"2025-07-18","type":"pipeline","source":"The Pharma Letter","summary":"TRIO Pharmaceuticals appoints Patrick Doyle CEO - The Pharma Letter","headline":"TRIO Pharmaceuticals appoints Patrick Doyle CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQNWVoVVdSQmZBa3QyQWpLVmliYU9VQTJfOU83U0E3NE9aVjhrX2lOaWsxRU10VUpuMDV2dnE1RmRBeHdsVFdUY2ZrWldCOVBmSWhiZTRMS3dQNXFVOXhfT3BsazFtMERjOW5kLTRiM01vS2JVU3Z1NE9sLUtGSVRMV1o4alNucUlDbzVj?oc=5","date":"2025-07-11","type":"pipeline","source":"statnews.com","summary":"Up and down the ladder: The latest comings and goings - statnews.com","headline":"Up and down the ladder: The latest comings and goings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYzZIaEo2TVlRVW9VamttYmplSWZuS24xbDMtMjhyZ2V4Z3g3UzVSWUF6dzRzV1lRdzdVUGpLMjBxTmkydnFmV25oZFVLb2JDVVVFX0JhTUhKdDhJeFJHZUowNmJyNjloTWhPeDNMUjJGTDYwbmVfYklnYlVpd0NiSWFuWkZmTTE0UTE3anFSUVJMVEJONFhjb0hsd1pQbUlEX28xcGdHaVNSaGVO?oc=5","date":"2025-06-27","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Incyte taps new CEO after longtime leader hangs up his hat - Fierce Biotech","headline":"Chutes & Ladders—Incyte taps new CEO after longtime leader hangs up his hat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE85TUFmV2RPbGc2T3dxRTNCX1cxZXkyME1fZ3BpMjNHd05VNXJ5Y1ZmakI1RlM4Y3BfTHR4c3h5czVhekxxTHo0U0ltMkQxUEZxSHNISHZBb0FuTXU3LXFBeA?oc=5","date":"2025-06-25","type":"pipeline","source":"The Pharma Letter","summary":"OnCusp Therapeutics - The Pharma Letter","headline":"OnCusp Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQai1ZMHhVUzZReHNsT3pnMmJpZ2J2bWY5U2tRUGI3bk9TTVBzWUF2YVNDNVN4T1kyX1M1ZHlzcXM2YTJZYjlJMmxURC1lYmJhTE1adms5YjlpVXZ5cEt3QWU4YnBReHl2dVhVUWVVSGRNS3RlSUUwNWZGUk8wNW5KNlk4bw?oc=5","date":"2025-06-16","type":"trial","source":"Oncology Pipeline","summary":"NextCure joins Merck in an ovarian target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"NextCure joins Merck in an ovarian target | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBibVFmckF2UU4xWWw3OWdGZ0dzOWZRcldRYUtxaTc1bXZqUVFVb0t5OWVJYXFRR1d3SzBqd0ttdXRvbHZJQVAySTh0MHhwSEczRXg2V0Y4UnRfZ0dzTEN0NGZyNDJ3M2VfNWlNNzNtLUZhZw?oc=5","date":"2025-06-03","type":"trial","source":"Clinical Trials Arena","summary":"ASCO25: OnCusp reports positive initial Phase Ia data from trial of CUSP06 - Clinical Trials Arena","headline":"ASCO25: OnCusp reports positive initial Phase Ia data from trial of CUSP06","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNNllSZ1k5SVVyazZ5RGNScklJOGczaXltUTRwcFhHVU9acjV5T1p0U0JoNFNoSnFSRzRaWkhpV0tBeWR1TWNhTFVQUTRfVVpyOXdxZFBOLVQtbk9lN0JJckFPMzRKNU81dTlaRjBGRkVQZ2lpSVY2OTltSHVMcGw5UnBldGJKRzJjc0xqYWRhOE9SaXQ0WmdmbU9xS1g?oc=5","date":"2025-03-03","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in February 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in February 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxNWTRreGdjblpXWTY0OFE4aWtKQ2R4a0N1TzJtZ2RsZFV5UmFhb3ZUR0tGQm5jdEFwUm9KQ3ZHZV9SRTZfOTBKTHJBMmZ2S0sxWURVNDAzS0JnSkJveDhpeTcycXFnY25pMXJ1YVEyYkJINkV0T216WlBORkJoRl9aM19JNDl1NnZEbm5NLUhZSUxYd3hmME1MVEFRckxVd1BHdmlINERQOFg2Vy1IMG94ejFyeFFxLWtRTHJHSU8xU0I1X0pFVzBxQmFLTDRJVXk1M2xKODJ2akRabExnQXhiLWRCbGx3c1owWmN1ZGVoSWF4Qy1uQmJ6ZDR6TW9GZDR2dWtaa0lCTVRzNjZ0OEhjMmE2SHNVR1ZyUTNrNGhDZEw0SnJpWnZzaTNYWV96UEVuVGc4b1VNOFJiTk5mN0FSYmdUZDcyX25HYk84WmU1WmI?oc=5","date":"2025-02-20","type":"pipeline","source":"GlobeNewswire","summary":"Antibody-Drug Conjugates Market to Witness Rapid Growth - GlobeNewswire","headline":"Antibody-Drug Conjugates Market to Witness Rapid Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPc1NGSmpzRjRkTUV2SllQaVN3UmtHY1JPUXFiWDIyQlo3bS1qYlFwMnVOeGZERkEwNnJRa2lnRlRlaXNHbEdSai1iUVpORjdQYzR3WDFoYnJhVGwxeW5GZTZ6a1YwOFZadF81Q3ZMWDhxcTJSbC1WRUVreW0yakZQNVVHdGl0d2pDczZPOEFndDR2VjEzWmQyT1pXalNFaU9EOTNOUllpcGFWX1FUWVk4QWo2U2p6TEZsTU1Ib3Jza2duWkQ5N2FJ?oc=5","date":"2025-02-13","type":"regulatory","source":"Pharmacy Times","summary":"CUSP06 Granted FDA Fast Track Designation for Patients With Platinum-Resistant Ovarian Cancer - Pharmacy Times","headline":"CUSP06 Granted FDA Fast Track Designation for Patients With Platinum-Resistant Ovarian Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOM21NWGJUU3VHRnF1NzFjNk1RelV4RGVxWXVYN19jNGhVNjZIekt5YktjYTRBejRQeGE2VWd6V0RESG92eldPZms4RDlFZ0kxWmdtb0Z2ODFtR1ZTQWJCM0Nha0p4YXhoazJrdV9rYzVUVDlxTnAyVXRMOTdkeTR1S3ZyMDJ3TW4xU3lQa0pNY1dzeGt1R0E4Xy14bFlISWJkck1WRUdDMTFzOW5YOWlHalB5ZmpZcWR2dGxNNTEzbGhyUklaZWtWMG9fTWU1NGtPRWRIS3AyanphRFhaYmQtTGRIX21YNkRKYS1aUDNRbFFjWnN3Ti1GX3JOc3Y?oc=5","date":"2024-10-17","type":"pipeline","source":"PR Newswire","summary":"200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight - PR Newswire","headline":"200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1TNUYwZ21GNUpJOVc2b1pQcGFvNS1jdEhTcTAtSmE5ZUk0RmhwX0l1Yy1XYnk3elVTR3V6M0tETExlbmxzQlFrSXJDX2txRk1jTHlHd1loazZiQzVCSUNFSjg1RlJVcTF4NDhaS3c2N2RodGdIcnc?oc=5","date":"2024-02-07","type":"pipeline","source":"Labiotech.eu","summary":"The biggest private biotech investments in January 2024 - Labiotech.eu","headline":"The biggest private biotech investments in January 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNRGQ0VklYVTVrTVdxQllkMzhla2hYdjdWQVN5SmNWUm5uUWJiS3ZrZVJZcEZzek5UT1h0VV9qc0RFN2c3UlVjZ2xmY3FDbHNnWFEwY244Z18wLU9kMURLd1VfTzRWZmJOZUh5TXBZVDNDcWdHc3hHRnduMzlMek12bkFPaUVLcVo5WmU5VHRJcWd6N3lmb21pLTFPd2d0Zw?oc=5","date":"2024-01-05","type":"pipeline","source":"BioSpace","summary":"ADC-Focused OnCusp Therapeutics Emerges with $100M Series A Raise - BioSpace","headline":"ADC-Focused OnCusp Therapeutics Emerges with $100M Series A Raise","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}